E-Cigarette Use Tied to Respiratory Symptoms, Wheezing
FRIDAY, Feb. 18, 2022 (HealthDay News) — Former and current electronic cigarette use is associated with higher odds of developing wheezing-related respiratory symptoms, according to a study published online Jan. 27 in the American Journal of Respirat…
Learn MoreFDA Warns of Infant Formula Powders Tied to Infections
FRIDAY, Feb. 18, 2022 (HealthDay News) — Several powdered infant formula products have been recalled by Abbott Inc., following reports of four infants developing bacterial infections after consuming the products, the U.S. Food and Drug Administration…
Learn MoreBrut, Sure Brand Deodorants Under Recall Due to Benzene
FRIDAY, Feb. 18, 2022 (HealthDay News) — Six Brut and Sure aerosol antiperspirant and deodorant sprays sold in the United States and Canada have been recalled by their maker due to the presence of the chemical benzene.”Benzene is classified as a huma…
Learn MoreScientists Report ‘Rogue Antibodies’ Behind Severe Clotting With COVID-19
FRIDAY, Feb. 18, 2022 (HealthDay News) — “Rogue antibodies” that seem to trigger severe blood clotting and illness in COVID-19 patients have been identified by scientists. The report was published online Feb. 17 in Arthritis & Rheumatology.Their anal…
Learn MoreRecommended Adult Immunization Schedule Updated for 2022
FRIDAY, Feb. 18, 2022 (HealthDay News) — The recommended immunization schedule for adults has been updated for 2022 and was published online Feb. 18 in the Annals of Internal Medicine and in the Feb. 18 issue of the U.S. Centers for Disease Control a…
Learn MoreModel Predicts 30-Day Mortality in Alcohol-Related Hepatitis
FRIDAY, Feb. 18, 2022 (HealthDay News) — A new scoring system can help identify individuals with alcohol-associated hepatitis (AH) who are at high risk for short-term mortality, according to a study published online Feb. 15 in the Mayo Clinic Proceed…
Learn MoreBridging Therapy May Be Better for Large Vessel Occlusion Stroke
FRIDAY, Feb. 18, 2022 (HealthDay News) — For patients with anterior circulation large vessel occlusion (LVO) stroke, use of intravenous thrombolysis followed by mechanical thrombectomy (MT; also known as bridging therapy [BT]) is associated with incr…
Learn MoreDaily Aspirin Does Not Prevent Recurrence of Breast Cancer
FRIDAY, Feb. 18, 2022 (HealthDay News) — Regular aspirin use does not improve invasive disease-free survival (iDFS) among high-risk breast cancer patients with human epidermal growth factor receptor 2 (HER2)-negative disease, according to a study pre…
Learn MoreHigh-Volume Surgeons Key to Survival in Open Repair for AAA
FRIDAY, Feb. 18, 2022 (HealthDay News) — Centers that meet the Society for Vascular Surgery (SVS) guidelines for elective open aortic abdominal aneurysm (AAA) repair are associated with improved patient survival, with surgeon volume confounding results, according to a study published in the February issue of the Journal of Vascular Surgery.
Joshua T. Geiger, from the University of Rochester Medical Center, and colleagues examined the effect of SVS guidelines on postoperative mortality and complications among patients who had undergone elective open AAA repair from 2003 to 2014. The cohort included 7,594 elective open AAA repairs performed by 542 surgeons at 137 hospitals.
The researchers found that for centers that were within the SVS guidelines, the one-year and 30-day mortality rates were 9.2 and 3.5 percent, respectively, compared with 13.6 and 6.9 percent, respectively, for those outside the guidelines. The one-year mortality hazard ratios were 0.80 (95 percent confidence interval, 0.70 to 0.93; P = 0.003), 0.91 (95 percent confidence interval, 0.77 to 1.08; P = 0.298), and 0.72 (95 percent confidence interval, 0.62 to 0.82; P
“This supports centralizing elective open AAA operations to higher-volume surgeons at high-quality centers,” a coauthor said in a statement. “This may have educational value for trainees as high-volume surgeons tend to practice at teaching hospitals.”
Learn MoreBaricitinib Reduces Mortality in Critically Ill Adults With COVID-19
FRIDAY, Feb. 18, 2022 (HealthDay News) — For critically ill hospitalized patients with COVID-19 receiving invasive mechanical ventilation or extracorporeal membrane oxygenation, baricitinib plus standard of care is associated with reduced mortality, …
Learn More